Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Hope for non-animal testing

Skin model proves a successful testing method

Researchers have found that a model replicating the traits of human skin could provide a replacement for animals in future clinical research.

A study taking place at the Flemish Institute for Technological Research (VITO) in Belgium, found that a skin sensitisation assay can successfully identify chemicals causing human allergic responses.

The research team used a three-dimensional, human-derived skin model, which replicates key traits of normal human skin.

This could replace the use of guinea pigs or mice, which are injected with or have substances applied to their skin to determine allergic reactions.

Researchers found that the model accurately predicated each chemical's ability to cause an allergic response for all of the compounds tested.

These findings support those reported by Michigan-based research organisation, CeeTox, who created the skin sensitisation assay.

Further validation studies will be carried out, and the results are to be submitted to the European Centre for the Validation of Alternative Methods, which officially approves the methods of chemical testing required by law.

The announcement follows a recent ban in Europe on the sale of cosmetics that have been tested on animals.

Related News
Committee to advise on research animals
Animals for scientific procedures consultation

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.